Please login to the form below

Not currently logged in
Email:
Password:

CRO

This page shows the latest CRO news and features for those working in and with pharma, biotech and healthcare.

AI specialist Exscientia buys Kinetic Discovery

AI specialist Exscientia buys Kinetic Discovery

Kinetic operates mainly as a contract research organisation (CRO) at present, providing services such as hit identification, confirmation and validation.

Latest news

  • Geron poleaxed as partner J&J abandons only pipeline drug Geron poleaxed as partner J&J abandons only pipeline drug

    He also noted that the company has hired a contract research organisation (CRO) to help ensure IMerge and an extended IMbark trial can continue without interruption.

  • New industry standards group launched New industry standards group launched

    New industry standards group launched. Align Clinical CRO will improve clinical trial collaboration. ... Align Clinical CRO represents an important industry collaboration to improve the trial processes and how the industry works together to accelerate

  • ICON boosts leadership teams ICON boosts leadership teams

    He has over 30 years of experience in pharmaceutical and contract research organisation (CRO) roles, joining from Quintiles where he led its global clinical analysis and reporting services group. ... Carroll has over 20 years of CRO and pharmaceutical

  • Gilead's ulcerative colitis antibody flunks trial Gilead's ulcerative colitis antibody flunks trial

    fibrosis. In the summer it was reported that Gilead and contract research organisation (CRO) partner Quintiles were struggling to recruit patients into its phase II Crohn's disease trial.

  • Takeda signs strategic-level outsourcing deal with PRA Takeda signs strategic-level outsourcing deal with PRA

    pharmacovigilance and other operational support - with 300 of the Japanese company's R&D staff set to transfer to the contract research organisation (CRO). ... level and is described by the CRO's chief executive Colin Shannon as "the first of its kind in

More from news
Approximately 39 fully matching, plus 85 partially matching documents found.

Latest Intelligence

  • Real patient voices Real patient voices

    The #Human behind every number project

  • Deal Watch February 2017 Deal Watch February 2017

    It is apparently eyeing a potential acquisition of the CRO PPD for around $8bn.

  • Deal Watch May 2016 Deal Watch May 2016

    Doing the complete opposite and consolidating, Quintiles and IMS Health announced the merger of their respective businesses to form a mega-CRO with a combined market capitalisation of $17.6bn.

  • The hidden costs of poor translation The hidden costs of poor translation

    Many CRO project managers complain that their current translation supplier gives them low quality translations and poor service. ... as stand-alone translations rather than translation tables, meaning that the CRO project managers (PMs) have to align

  • Deal Watch table for April 2014 Deal Watch table for April 2014

    Aptiv Solutions/ ICON. Acquisition. CRO/ Adaptive Clinical Trials. 143.5. California Stem Cell/ NeoStem.

More from intelligence
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest appointments

  • Metrion Biosciences adds to its board Metrion Biosciences adds to its board

    Barry’s substantial experience of drug discovery deal-making will be of great value to Metrion as we continue to build our worldwide CRO and collaboration business, and Andy’s dedication

  • Lynn Lewis joins Envigo Lynn Lewis joins Envigo

    Lynn Lewis joins Envigo. She becomes the CRO’s senior vice president of global sales.

  • Remi Gauchoux joins Carenity Remi Gauchoux joins Carenity

    Gauchoux has a 20-year international experience in healthcare and the CRO industries with expertise in late phase and real-world evidence analysis. ... His career has seen him work for Mapi Group, where he held the role of senior director in global

  • Dr Martine Dehlinger-Kremer becomes EUCROF president Dr Martine Dehlinger-Kremer becomes EUCROF president

    Dr Dehlinger-Kremer has over 30 years of clinical research industry experience and currently serves as vice president for global medical and regulatory affairs at San Diego, US-based CRO SynteractHCR.

  • Metrion Biosciences expands operations team Metrion Biosciences expands operations team

    Dr Marc Rogers, chief scientific officer at Metrion Biosciences, said: “ Since becoming an independent CRO in 2015 Metrion has grown rapidly. “

More from appointments
Approximately 12 fully matching, plus 53 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 51 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics